Arthur P. Bedrosian

No open positions remaining

80 year

Health Technology

Consumer Services

Profile

Arthur P.
Bedrosian served as the Chief Executive Officer & Director of Lannett Co., Inc. from 2014 to 2018.
Prior to that, he was the President & Chief Executive Officer of Trinity Laboratories, Inc. from 1999 to 2001.
He also served as the President & Chief Executive Officer of Kremers Urban Pharmaceuticals, Inc. Bedrosian received his undergraduate degree from Queens College and his graduate degree from Newport University.

Former positions of Arthur P. Bedrosian

Companies	Position	End
LANNETT COMPANY, INC.	Chief Executive Officer	2018-01-01
Trinity Laboratories, Inc. Trinity Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	President	2000-12-31
Kremers Urban Pharmaceuticals, Inc. Kremers Urban Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a generic pharmaceutical company	Chief Executive Officer	-

See the detail of Arthur P. Bedrosian's experience

Training of Arthur P. Bedrosian

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Arthur P. Bedrosian's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Lannett Co., Inc. Lannett Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products	Health Technology
Queens College Queens College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trinity Laboratories, Inc. Trinity Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology
Newport University Newport University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kremers Urban Pharmaceuticals, Inc. Kremers Urban Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a generic pharmaceutical company	Health Technology